Utility of PCD Diagnostics to Improve Clinical Care
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 1 - Any |
| Updated: | 10/14/2018 |
| Start Date: | June 1, 2017 |
| End Date: | June 1, 2020 |
| Contact: | Michael O'Connor, MD |
| Email: | michael.g.oconnor@vumc.org |
| Phone: | 615.343.7617 |
This is a study evaluating the utility of current Primary Ciliary Dyskinesia (PCD) diagnostic
tests, including nasal nitric oxide testing.
tests, including nasal nitric oxide testing.
This study is a prospective data collection of individuals referred to the investigators
clinical center for considerations of PCD. Participants sign informed consent to have
clinical information entered into a secure electronic database. As part of this study,
participants may have nasal nitric oxide (nNO) testing performed. nNO testing is a research
procedure, but it is a test with growing utility for making a diagnosis of PCD when performed
in the right clinical setting.
clinical center for considerations of PCD. Participants sign informed consent to have
clinical information entered into a secure electronic database. As part of this study,
participants may have nasal nitric oxide (nNO) testing performed. nNO testing is a research
procedure, but it is a test with growing utility for making a diagnosis of PCD when performed
in the right clinical setting.
Inclusion Criteria:
- Referred to center for PCD diagnosis considerations
- Ability to perform study procedures
- Age greater than 2 years of age
Exclusion Criteria:
- Age less than 2 years of age Inability to perform informed consent
We found this trial at
1
site
Vanderbilt Children's Hospital Monroe Carell Jr. Children's Hospital at Vanderbilt is one of the nation's...
Click here to add this to my saved trials
